Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID TAMURA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1295953123
CMS profile
58967
Location
HONOLULU, HI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$5,653.54

175 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,766.22 173
Consulting Fee $780.00 1
Education $107.32 1

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Geron Corporation $807.17 3
AstraZeneca Pharmaceuticals LP $336.89 11
Astellas Pharma US Inc $321.50 5
PFIZER INC. $249.17 9
Incyte Corporation $239.91 10
Exelixis Inc. $217.00 5
Lilly USA, LLC $197.84 6
ABBVIE INC. $183.95 12
Caris MPI, Inc. $175.21 2
Janssen Biotech, Inc. $174.64 7
Karyopharm Therapeutics Inc. $164.20 3
Novartis Pharmaceuticals Corporation $156.48 7
Aveo Pharmaceuticals, Inc. $152.90 4
JAZZ PHARMACEUTICALS INC. $131.09 4
BioMarin Pharmaceutical Inc. $119.86 1
Daiichi Sankyo Inc. $100.36 4
TerSera Therapeutics LLC $96.28 3
Merck Sharp & Dohme LLC $82.70 4
Spectrum Pharmaceuticals Inc. $82.04 2
BeOne Medicines USA, Inc. $78.48 3
Pharmacosmos Therapeutics Inc. $76.83 3
Tempus AI, Inc $68.48 3
PUMA BIOTECHNOLOGY, INC. $67.37 3
Rigel Pharmaceuticals, Inc. $66.95 3
GENZYME CORPORATION $65.37 3
Syndax Pharmaceuticals, Inc. $60.70 2
Regeneron Healthcare Solutions, Inc. $59.98 2
Genentech USA, Inc. $57.01 2
Adaptive Biotechnologies Corporation $53.89 3
Coherus Oncology, Inc. $52.43 2
Azurity Pharmaceuticals, Inc. $47.87 2
Eisai Inc. $47.31 2
Kite Pharma, Inc. $45.88 2
Genmab U.S., Inc. $45.50 2
Celgene Corporation $43.38 3
GlaxoSmithKline, LLC. $43.01 2
Takeda Pharmaceuticals U.S.A., Inc. $42.72 2
TAIHO ONCOLOGY, INC. $42.43 2
IMMUNITYBIO, INC. $42.17 2
Stemline Therapeutics Inc. $36.29 2
Chiesi USA, Inc. $35.43 2
Acrotech Biopharma Inc. $34.55 2
Ipsen Biopharmaceuticals, Inc $34.26 1
BeiGene USA, Inc. $33.52 1
RECORDATI_RARE_DISEASES_INC. $33.41 1
E.R. Squibb & Sons, L.L.C. $32.59 2
ARRAY BIOPHARMA INC $29.60 1
SpringWorks Therapeutics, Inc. $28.42 1
PharmaEssentia USA Corporation $26.83 1
Ferring Pharmaceuticals Inc. $24.84 1
Novo Nordisk Inc $24.79 1
Verity Pharmaceuticals Inc. $24.04 1
Amgen Inc. $23.90 1
KYOWA KIRIN, INC. $22.06 1
Alexion Pharmaceuticals, Inc. $21.05 1
Fennec Pharmaceuticals, Inc. $19.88 1
Agios Pharmaceuticals, Inc. $18.60 1
Menarini Silicon Biosystems, Inc. $18.41 1
EMD Serono, Inc. $17.46 1
Janssen Scientific Affairs, LLC $16.66 1

Page 3 of 4; records 101–150 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID TAMURA

NPI 1295953123 · CMS profile ID 58967

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

HONOLULU, HI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1295953123?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID TAMURA, NPI 1295953123, CMS profile ID 58967. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1295953123?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). DAVID TAMURA, NPI 1295953123, CMS profile ID 58967. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1295953123?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
DAVID TAMURA, NPI 1295953123, CMS profile ID 58967, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1295953123?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

175 matching records · $5,653.54 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 175 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 175.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Menarini Silicon Biosystems, Inc. $18.4106/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1199866019 CMS
Syndax Pharmaceuticals, Inc. $34.6406/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238996412 CMS
Pharmacosmos Therapeutics Inc. $22.3505/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250731268 CMS
Astellas Pharma US Inc $20.2205/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238792675 CMS
AstraZeneca Pharmaceuticals LP $21.3305/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207283816 CMS
Incyte Corporation $27.0805/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226114500 CMS
Lilly USA, LLC $24.8205/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186653521 CMS
AstraZeneca Pharmaceuticals LP $121.9205/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206847496 CMS
PFIZER INC. $23.6205/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229642206 CMS
Daiichi Sankyo Inc. $25.4605/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197093469 CMS
Karyopharm Therapeutics Inc. $25.2905/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246643928 CMS
Aveo Pharmaceuticals, Inc. $39.6905/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1199898830 CMS
Celgene Corporation $14.6605/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184516065 CMS
TerSera Therapeutics LLC $21.7305/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244055055 CMS
Ipsen Biopharmaceuticals, Inc $34.2605/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208833451 CMS
Daiichi Sankyo Inc. $20.2604/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197054047 CMS
Merck Sharp & Dohme LLC $20.3504/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238307256 CMS
JAZZ PHARMACEUTICALS INC. $39.3504/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234314643 CMS
BioMarin Pharmaceutical Inc. $119.8604/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249730485 CMS
E.R. Squibb & Sons, L.L.C. $15.1304/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184516047 CMS
Regeneron Healthcare Solutions, Inc. $25.2204/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213055748 CMS
GENZYME CORPORATION $23.6904/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233396050 CMS
Novo Nordisk Inc $24.7904/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189151181 CMS
Novartis Pharmaceuticals Corporation $32.6204/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200530962 CMS
Stemline Therapeutics Inc. $15.7104/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244091654 CMS
Exelixis Inc. $29.9604/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218793259 CMS
Incyte Corporation $2.8303/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226073424 CMS
Incyte Corporation $18.9003/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226073544 CMS
AstraZeneca Pharmaceuticals LP $17.1603/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206287692 CMS
Karyopharm Therapeutics Inc. $20.1603/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246643924 CMS
ABBVIE INC. $13.1303/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204476358 CMS
PFIZER INC. $32.7303/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229596103 CMS
PFIZER INC. $28.0303/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229595559 CMS
Adaptive Biotechnologies Corporation $19.1703/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1254939914 CMS
Geron Corporation $6.1303/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238894942 CMS
Geron Corporation $21.0403/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238894947 CMS
Janssen Biotech, Inc. $29.6303/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175418238 CMS
PUMA BIOTECHNOLOGY, INC. $21.4903/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251745984 CMS
Celgene Corporation $15.1003/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184516025 CMS
IMMUNITYBIO, INC. $17.6403/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233173350 CMS
PFIZER INC. $19.0003/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229575303 CMS
Lilly USA, LLC $107.3203/04/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1186572050 CMS
Merck Sharp & Dohme LLC $24.6603/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238270460 CMS
Karyopharm Therapeutics Inc. $118.7502/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246643931 CMS
Eisai Inc. $26.5302/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244474951 CMS
PUMA BIOTECHNOLOGY, INC. $20.6902/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251741872 CMS
Rigel Pharmaceuticals, Inc. $22.9102/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247370123 CMS
Astellas Pharma US Inc $16.5302/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238744998 CMS
Exelixis Inc. $19.8402/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218793257 CMS
Celgene Corporation $13.6202/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184516005 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,771.19 120
PY2020 $7,047.21 103
PY2021 $4,995.38 117
PY2022 $3,081.91 115
PY2023 $3,331.44 124
PY2024 $4,009.51 144
PY2025 $5,653.54 175

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $15,091.00 4
PY2022 Principal investigator $31,509.00 9
PY2020 Principal investigator $3,000.00 2
PY2019 Principal investigator $20,059.12 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $10,782.00 07/03/2023 Non-covered Recipient Entity
INNOVATION CLINICAL RESEARCH OF THE PACIFIC INC
Biomarker Study to Determine Frequency of DNA repair Defects in Men with Metastatic Prostate Cancer No dispute reported 06/30/2026 986158007
Principal investigator 1 Janssen Research & Development, LLC $1,847.00 04/10/2023 Non-covered Recipient Entity
INNOVATION CLINICAL RESEARCH OF THE PACIFIC INC
A Phase 2 Study of Erdafitinib in Subjects with Advanced Solid Tumors and FGFR Gene Alterations No dispute reported 06/30/2026 986158005
Principal investigator 1 Janssen Research & Development, LLC $1,231.00 02/23/2023 Non-covered Recipient Entity
INNOVATION CLINICAL RESEARCH OF THE PACIFIC INC
A Phase 2 Study of Erdafitinib in Subjects with Advanced Solid Tumors and FGFR Gene Alterations No dispute reported 06/30/2026 986158001
Principal investigator 1 Janssen Research & Development, LLC $1,231.00 01/23/2023 Non-covered Recipient Entity
INNOVATION CLINICAL RESEARCH OF THE PACIFIC INC
A Phase 2 Study of Erdafitinib in Subjects with Advanced Solid Tumors and FGFR Gene Alterations No dispute reported 06/30/2026 986158003